SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
26-Sep-23 4:30 PM View: | Reata Pharmaceuticals Inc (RETA) | 26-Sep-23 | Disposition | 45,000 | -- | -- | (100%) 45.0K to 0 | |
14-Jun-23 4:26 PM View: | Reata Pharmaceuticals Inc (RETA) | 12-Jun-23 | Grant | 45,000 | -- | -- | 100% 0 to 45.0K | |
03-Mar-20 7:02 PM View: | Portola Pharmaceuticals Inc (PTLA) | 28-Feb-20 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K | |
10-Apr-19 4:26 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 08-Apr-19 | Grant | 30,000 | -- | -- | 157% 19.14K to 49.14K | |
21-Mar-19 4:45 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Mar-19 | Market Sale | 2,374 | $8.00 | $18,992.00 | (11%) 21.52K to 19.14K | (3%) |
22-Mar-18 5:51 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Mar-18 | Market Sale | 1,252 | $25.94 | $32,476.90 | (5%) 22.77K to 21.52K | 68% |
09-Mar-18 8:50 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 06-Mar-18 | Grant | 9,125 | -- | -- | 67% 13.64K to 22.77K | |
22-Mar-17 5:05 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Mar-17 | Market Sale | 733 | $17.04 | $12,490.30 | (5%) 14.38K to 13.64K | 52% |
20-Jan-17 6:14 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 18-Jan-17 | Grant | 6,875 | -- | -- | 92% 7.5K to 14.38K | |
08-Mar-16 5:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 04-Mar-16 | Grant | 7,500 | $13.66 | $102,450.00 | 100% 0 to 7.5K | (45%) |
07-May-15 5:19 PM View: | Tranzyme, Inc. (OCRX) | 07-May-15 | Market Purchase | 5,050 | $3.97 | $20,048.50 | 100% 0 to 5.05K | (55%) |